
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is a leading medical technology firm with a diverse sales portfolio and a strong presence in key global markets. The company has shown consistent revenue growth and has a positive outlook for the future, driven by factors such as a healthy US capital equipment environment, potential for growth in radiopharmaceuticals, and the reduced risk of GE selling its shares. While trade-war and inflationary impacts may have affected the company in the near term, GEHC's strong operational performance and ability to adapt to changing market dynamics suggest it is well-positioned for long-term success.
Bears say
GE HealthCare Techs is facing several challenges that could negatively impact its stock, including margin pressures from inflation and tariffs as well as slowing revenue growth. While the company is investing in new products and markets, it still faces competition from other healthcare technology firms. Additionally, its heavy reliance on the financial health of its clients makes it vulnerable to any slowdown in clinical trial activity or R&D investments. While there is potential for upside, particularly with the recovery of the biopharma industry, risks remain, including potential security breaches and declines in demand for its solutions.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares